Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Lawrence

Showing results (41-50 of 135) with videos related to

Pageof 14
Sort By:
Phlebology|January 22, 2026
PAI-1 Inhibition in experimental venous thrombosisMaxim E Shaydakov, Cory D Emal, Joshua P Rainey, et al.
The Journal of Clinical Investigation|August 5, 2003
A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritisYufeng Huang, Masashi Haraguchi, Daniel A Lawrence, et al.
The Journal of Biological Chemistry|October 3, 2003
The low density lipoprotein receptor-related protein modulates protease activity in the brain by mediating the cellular internalization of both neuroserpin and neuroserpin-tissue-type plasminogen activator complexesAlexandra Makarova, Irina Mikhailenko, Thomas H Bugge, et al.
Thrombosis and Haemostasis|July 23, 2004
Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous systemTambet Teesalu, Andres Kulla, Aadu Simisker, et al.
Journal of the American Society of Nephrology : JASN|January 25, 2008
A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathyYufeng Huang, Wayne A Border, Ling Yu, et al.
Journal of Neuroinflammation|March 2, 2023
Opposing effects of β-2 and β-1 adrenergic receptor signaling on neuroinflammation and dopaminergic neuron survival in α-synuclein-mediated neurotoxicityDaniel Torrente, Enming J Su, Gerald P Schielke, et al.
The Journal of Biological Chemistry|May 18, 2010
Low density lipoprotein receptor-related protein-1 (LRP1) regulates thrombospondin-2 (TSP2) enhancement of Notch3 signalingHe Meng, Xiaojie Zhang, Soo Jung Lee, et al.
Viruses|February 13, 2015
Elevated cytokines, thrombin and PAI-1 in severe HCPS patients due to Sin Nombre virusVirginie Bondu, Ron Schrader, Mary Ann Gawinowicz, et al.
The Journal of Clinical Investigation|November 18, 2003
Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related proteinManuel Yepes, Maria Sandkvist, Elizabeth G Moore, et al.
Blood|December 16, 2006
Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unitRohini Polavarapu, Maria Carolina Gongora, Hong Yi, et al.
Pageof 14

Showing results (41-50 of 135) with videos related to

Sort By:
Pageof 14
Phlebology|January 22, 2026
PAI-1 Inhibition in experimental venous thrombosisMaxim E Shaydakov, Cory D Emal, Joshua P Rainey, et al.
The Journal of Clinical Investigation|August 5, 2003
A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritisYufeng Huang, Masashi Haraguchi, Daniel A Lawrence, et al.
The Journal of Biological Chemistry|October 3, 2003
The low density lipoprotein receptor-related protein modulates protease activity in the brain by mediating the cellular internalization of both neuroserpin and neuroserpin-tissue-type plasminogen activator complexesAlexandra Makarova, Irina Mikhailenko, Thomas H Bugge, et al.
Thrombosis and Haemostasis|July 23, 2004
Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous systemTambet Teesalu, Andres Kulla, Aadu Simisker, et al.
Journal of the American Society of Nephrology : JASN|January 25, 2008
A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathyYufeng Huang, Wayne A Border, Ling Yu, et al.
Journal of Neuroinflammation|March 2, 2023
Opposing effects of β-2 and β-1 adrenergic receptor signaling on neuroinflammation and dopaminergic neuron survival in α-synuclein-mediated neurotoxicityDaniel Torrente, Enming J Su, Gerald P Schielke, et al.
The Journal of Biological Chemistry|May 18, 2010
Low density lipoprotein receptor-related protein-1 (LRP1) regulates thrombospondin-2 (TSP2) enhancement of Notch3 signalingHe Meng, Xiaojie Zhang, Soo Jung Lee, et al.
Viruses|February 13, 2015
Elevated cytokines, thrombin and PAI-1 in severe HCPS patients due to Sin Nombre virusVirginie Bondu, Ron Schrader, Mary Ann Gawinowicz, et al.
The Journal of Clinical Investigation|November 18, 2003
Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related proteinManuel Yepes, Maria Sandkvist, Elizabeth G Moore, et al.
Blood|December 16, 2006
Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unitRohini Polavarapu, Maria Carolina Gongora, Hong Yi, et al.
Pageof 14